BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/21/2026 9:00:13 AM | Browse: 74 | Download: 410
 |
Received |
|
2025-12-23 10:58 |
|
Peer-Review Started |
|
2025-12-23 10:58 |
|
First Decision by Editorial Office Director |
|
2026-01-22 08:32 |
|
Return for Revision |
|
2026-01-22 08:32 |
|
Revised |
|
2026-01-25 09:32 |
|
Publication Fee Transferred |
|
2026-01-29 11:55 |
|
Second Decision by Editor |
|
2026-03-05 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-05 07:14 |
|
Articles in Press |
|
2026-03-05 07:14 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-03 01:57 |
|
Publish the Manuscript Online |
|
2026-04-21 09:00 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Three kinds of drug-eluting bead transarterial chemoembolisation for treating patients with unresectable non-small cell lung cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hui-Feng Yuan, Dong-Lin Kuang, De-Chao Jiao and Yong-Hua Bi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yong-Hua Bi, Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou 450052, Henan Province, China. 274233911@qq.com |
| Key Words |
Lung cancer; Drug-eluting beads transarterial chemoembolization; Doxorubicin; Oxaliplatin; Gemcitabine |
| Core Tip |
This is a retrospective single-center observational study to investigate the safety, effectiveness and cost-effectiveness of doxorubicin (DOX), oxaliplatin (OXA) and gemcitabine (GEM) drug-eluting bead transarterial chemoembolisation (DEB-TACE) in treating patients with unresectable non-small cell lung cancer (NSCLC). Our study indicates that DOX, OXA and GEM-eluting DEB-TACE may be an effective and safe treatment approach for unresectable NSCLC, with patients in the OXA group potentially exhibiting a prolonged overall survival. |
| Publish Date |
2026-04-21 09:00 |
| Citation |
Yuan HF, Kuang DL, Jiao DC, Bi YH. Three kinds of drug-eluting bead transarterial chemoembolisation for treating patients with unresectable non-small cell lung cancer. World J Clin Oncol 2026; 17(4): 118070
|
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i4/118070.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i4.118070 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
